Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Berke

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Journal of Virological Methods|February 16, 2010
Development of a high-content screening assay to identify compounds interfering with the formation of the hepatitis C virus replication complexJan Martin Berke, Denis Fenistein, Frederik Pauwels, et al.
ACS Nano|March 13, 2023
Signatures of Gate-Driven Out-of-Equilibrium Superconductivity in Ta/InAs NanowiresTosson Elalaily, Martin Berke, Máté Kedves, et al.
The Journal of Antimicrobial Chemotherapy|May 18, 2020
Anti-HBV activity of the HBV capsid assembly modulator JNJ-56136379 across full-length genotype A-H clinical isolates and core site-directed mutants in vitroThierry Verbinnen, Ying Tan, Gengyan Wang, et al.
Journal of Virological Methods|April 11, 2021
Development of a cellular high-content, immunofluorescent HBV core assay to identify novel capsid assembly modulators that induce the formation of aberrant HBV core structuresSarah Sauviller, Karen Vergauwen, Steffen Jaensch, et al.
Journal of Hepatology|November 13, 2012
Virologic response and characterisation of HCV genotype 2-6 in patients receiving TMC435 monotherapy (study TMC435-C202)Oliver Lenz, Leen Vijgen, Jan Martin Berke, et al.
Nature Communications|October 23, 2024
Switching dynamics in Al/InAs nanowire-based gate-controlled superconducting switchTosson Elalaily, Martin Berke, Ilari Lilja, et al.
Advances in Therapy|July 4, 2019
Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy SubjectsJoris Vandenbossche, Wolfgang Jessner, Maarten van den Boer, et al.
ACS Nano|October 31, 2025
Correction to "Multimode Operation of a Superconducting Nanowire Switch in the Nanosecond Regime"Zoltán Scherübl, Mátyás Kocsis, Tosson Elalaily, et al.
Journal of Viral Hepatitis|June 25, 2020
Virology analysis of chronic hepatitis B virus-infected patients treated for 28 days with JNJ-56136379 monotherapyThierry Verbinnen, Moana Hodari, Willem Talloen, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 6, 2012
MAPPIT as a high-throughput screening assay for modulators of protein-protein interactions in HIV and HCVBertrand Van Schoubroeck, Koen Van Acker, Géry Dams, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Journal of Virological Methods|February 16, 2010
Development of a high-content screening assay to identify compounds interfering with the formation of the hepatitis C virus replication complexJan Martin Berke, Denis Fenistein, Frederik Pauwels, et al.
ACS Nano|March 13, 2023
Signatures of Gate-Driven Out-of-Equilibrium Superconductivity in Ta/InAs NanowiresTosson Elalaily, Martin Berke, Máté Kedves, et al.
The Journal of Antimicrobial Chemotherapy|May 18, 2020
Anti-HBV activity of the HBV capsid assembly modulator JNJ-56136379 across full-length genotype A-H clinical isolates and core site-directed mutants in vitroThierry Verbinnen, Ying Tan, Gengyan Wang, et al.
Journal of Virological Methods|April 11, 2021
Development of a cellular high-content, immunofluorescent HBV core assay to identify novel capsid assembly modulators that induce the formation of aberrant HBV core structuresSarah Sauviller, Karen Vergauwen, Steffen Jaensch, et al.
Journal of Hepatology|November 13, 2012
Virologic response and characterisation of HCV genotype 2-6 in patients receiving TMC435 monotherapy (study TMC435-C202)Oliver Lenz, Leen Vijgen, Jan Martin Berke, et al.
Nature Communications|October 23, 2024
Switching dynamics in Al/InAs nanowire-based gate-controlled superconducting switchTosson Elalaily, Martin Berke, Ilari Lilja, et al.
Advances in Therapy|July 4, 2019
Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy SubjectsJoris Vandenbossche, Wolfgang Jessner, Maarten van den Boer, et al.
ACS Nano|October 31, 2025
Correction to "Multimode Operation of a Superconducting Nanowire Switch in the Nanosecond Regime"Zoltán Scherübl, Mátyás Kocsis, Tosson Elalaily, et al.
Journal of Viral Hepatitis|June 25, 2020
Virology analysis of chronic hepatitis B virus-infected patients treated for 28 days with JNJ-56136379 monotherapyThierry Verbinnen, Moana Hodari, Willem Talloen, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 6, 2012
MAPPIT as a high-throughput screening assay for modulators of protein-protein interactions in HIV and HCVBertrand Van Schoubroeck, Koen Van Acker, Géry Dams, et al.
Pageof 4